Brinzolamide Structural Formula (Azopt 01)
Azopt Suspension/ Drops
Product Images NDC 66758-085
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Azopt (NDC 66758-085). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
France-carton (France Carton)
This text is an informative label for an ophthalmic suspension containing the active ingredient brinzanide 10 mg. The product is manufactured by Alcon Laboratories and distributed by Sandozlnc. It provides instructions for use, dosage, storage conditions, and warnings. The medication is intended for topical ophthalmic use only and is a 1% suspension.*
Switzerland-carton (Switzerland Carton)
This is product information for brinzolamide ophthalmic suspension, with each container containing 10 mg of active ingredient. The suspension is for topical ophthalmic use and should be stored between 4°C to 30°C. The recommended dosage is one drop in the affected eye(s) three times daily. It is important to shake the suspension well before use and to avoid touching the dropper tip to prevent contamination. The product is manufactured by Alcon Laboratories in Fort Worth, Texas, for Sandoz Inc., and is a product of Switzerland.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
